Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential
- 16 June 2012
- journal article
- research article
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 17 (6) , 951-960
Abstract
A series of cationic dinuclear p-cymene ruthenium trithiophenolato complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+ (1 X is H, 2 X is Me, 3 X is Ph, 4 X is Br, 5 X is OH, 6 X is NO2, 7 X is OMe, 8 X is CF3, 9 X is F, 10 X is Pr i , 11 X is Bu t ) have been synthesized from the reaction of [(η6-p-MeC6H4Pr i )RuCl2]2 with the corresponding thiol, isolated as the chloride salts, and further studied for their electrochemical properties, cytotoxicity towards human ovarian cancer cells, and catalytic activity for glutathione (GSH) oxidation. Complex 1 was also compared with the benzene and hexamethylbenzene analogues [(η6-C6H6)2Ru2(SC6H5)3]+ (12) and [(η6-C6Me6)2Ru2(SC6H5)3]+ (13). The most active compound [11]Cl was structurally studied by single-crystal X-ray diffraction analysis. The concentrations corresponding to 50 % inhibition of cancer cell growth (IC50 values) in the A2780 and A2780cisR cell lines of these complexes except for 6 were in the submicromolar range, complex 11 showing an IC50 value of 0.03 µM in both cell lines. The high in vitro anticancer activity of these complexes may be at least partially due to their catalytic potential for the oxidation of GSH, although there is no clear correlation between the IC50 values and the turnover frequencies at about 50 % conversion. However, the cytotoxicity is tentatively correlated to the physicochemical properties of the compounds determined by the electronic influence of the substituents X (Hammett constants σ p) and the lipophilicity of the thiols p-XC6H4SH (calculated log P parameters).Keywords
This publication has 40 references indexed in Scilit:
- Biomolecule binding vs. anticancer activity: Reactions of Ru(arene)[(thio)pyr-(id)one] compounds with amino acids and proteinsJournal of Inorganic Biochemistry, 2011
- Expression of Glutathione Reductase Splice Variants in Human TissuesBiochemical Genetics, 2010
- Influence of the Arene Ligand, the Number and Type of Metal Centers, and the Leaving Group on thein VitroAntitumor Activity of Polynuclear Organometallic CompoundsOrganometallics, 2009
- Transferring the Concept of Multinuclearity to Ruthenium Complexes for Improvement of Anticancer ActivityJournal of Medicinal Chemistry, 2009
- Catalytic organometallic anticancer complexesProceedings of the National Academy of Sciences, 2008
- Influence of the Spacer Length on the in Vitro Anticancer Activity of Dinuclear Ruthenium−Arene CompoundsOrganometallics, 2008
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Tuning the hydrophobicity of ruthenium(ii)–arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacyDalton Transactions, 2007
- Redox behavior of tumor-inhibiting ruthenium(iii) complexes and effects of physiological reductants on their binding to GMPDalton Transactions, 2006
- Reactions of Potent Antitumor Complextrans-[RuIIICl4(indazole)2]-with a DNA-Relevant Nucleobase and Thioethers: Insight into Biological ActionInorganic Chemistry, 2004